Skip to main content
. 2021 Sep 12;12(3):541–549. doi: 10.34172/apb.2022.058

Table 1. Composition of different niosomal formulation containing ALA .

Name Constituents of lipid phase Molar ratio
F 1 Span20/Tween20/Cholesterol 25/25/50
F 2 Span20/Tween20/Cholesterol 30/30/40
F 3 Span20/Tween20/Cholesterol 35/35/30
F 4 Span40/Tween40/Cholesterol 25/25/50
F 5 Span40/Tween40/Cholesterol 30/30/40
F 6 Span40/Tween40/Cholesterol 35/35/30
F 7 Span60/Tween60/Cholesterol 25/25/50
F 8 Span60/Tween60/Cholesterol 30/30/40
F 9 Span60/Tween60/Cholesterol 35/35/30